Consolidated balance sheets - USD ($)
$ in Millions
Jun. 30, 2020
Dec. 31, 2019
Non-current assets [abstract]    
Property, plant and equipment $ 11,955 $ 12,069
Right-of-use assets 1,640 1,677
Goodwill 29,100 26,524
Intangible assets other than goodwill 36,669 28,787
Investments in associated companies 8,575 8,644
Deferred tax assets 8,601 7,909
Financial assets 2,475 2,518
Other non-current assets 866 738
Total non-current assets 99,881 88,866
Current assets [abstract]    
Inventories 6,904 5,982
Current trade receivables 7,644 8,301
Income tax receivable 308 254
Marketable securities, commodities, time deposits and derivative financial instruments 376 334
Cash and cash equivalents 5,917 11,112
Other current assets 2,733 2,680
Total current assets without disposal group 23,882 28,663
Assets of disposal group held for sale   841
Total current assets 23,882 29,504
Total assets 123,763 118,370
Equity [abstract]    
Share capital 913 936
Treasury shares (37) (80)
Reserves 52,936 54,618
Issued share capital and reserves attributable to Novartis AG shareholders 53,812 55,474
Non-controlling interests 73 77
Total equity 53,885 55,551
Non-current liabilities [abstract]    
Financial debts 23,955 20,353
Lease liabilities 1,698 1,703
Deferred tax liabilities 7,499 5,867
Provisions and other non-current liabilities 7,344 6,632
Total non-current liabilities 40,496 34,555
Current liabilities [abstract]    
Trade payables 4,820 5,424
Financial debts and derivative financial instruments 8,875 7,031
Lease liabilities 258 246
Current income tax liabilities 2,571 2,194
Provisions and other current liabilities 12,858 13,338
Total current liabilities without disposal group 29,382 28,233
Liabilities of disposal group held for sale   31
Total current liabilities 29,382 28,264
Total liabilities 69,878 62,819
Total equity and liabilities $ 123,763 $ 118,370